Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.
Clinical trial NCT04915768 · COMPLETED
Trial details
- NCT number
- NCT04915768
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2025-07-15
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.